Advisor, US Launch Excellence & Global PCAP Lead
Elanco
Summary
Elanco Animal Health Incorporated is a global leader in the animal health pharmaceutical industry, dedicated to improving the health and well-being of both pets and farm animals worldwide. Founded in 1954 as a division of Eli Lilly and Company, Elanco became an independent public company in 2018 and has since grown to become the world's second-largest independent animal health company. With approximately 9,000 employees globally, the company operates with a clear purpose: 'making life better for animals, makes life better.' Elanco develops innovative medicines, vaccines, and health solutions that empower veterinarians, farmers, and pet owners to advance animal care. The company maintains a balanced portfolio between pet health and farm animal products, offering over 200 brands that address critical health challenges ranging from companion animal diseases to livestock productivity. Headquartered in Indianapolis, Indiana, Elanco is publicly traded on the New York Stock Exchange (NYSE: ELAN) and continues to drive innovation in animal health through strategic acquisitions and dedicated research and development efforts.
Job description
Your day-to-day will include:
- Guide and mentor a multidisciplinary team responsible for advancing Elanco’s commercial success.
- This role will provide strategic oversight for two critical functions: ensuring the seamless
- Serve as a key liaison to senior stakeholders, guiding cross-functional teams to bring innovative pipeline assets to market.
- Manage product changes, including the geo-expansion strategy, effectively across the globe.
- Oversee, coach, and develop a high-performing team responsible for the successful execution of all US product launches and the management of the global PCAP process.
- Provide strategic oversight for all US launch readiness initiatives, ensuring alignment with the company’s commercial objectives and optimizing speed to market to maximize value creation.
- Direct the global Product Change Alignment Process (PCAP), overseeing prioritization of geo-expansions and ensuring the framework operates efficiently.
- Drive continuous improvement and strategic evolution of the Launch Excellence and PCAP frameworks to enhance efficiency and accelerate time-to-market.
- Influence key decisions by managing cross-functional governance, removing roadblocks, and reporting on launch status and PCAP metrics to senior stakeholders.
- Supervises 4 subordinates: Senior Consultant, Launch Leader, US PH Vet; Senior Associate Manager, Launch Leader, US PH OTV; Senior Associate Manager, Launch Leader, US Farm Animal; and Senior Analyst, PCAP & Portfolio Optimization (US-based).
You have the following technical skills and qualifications:
- Requirement – Bachelor’s degree in Veterinary Science, a related field, or a foreign equivalent plus 5 years of progressively responsible experience in job offered or any product-launch related roles.
- Relevant experience – Applicant must have 5 years of experience in the following: (1) applying knowledge of veterinary products, clinical knowledge of animal health, disease treatment, and veterinary practice environments for product commercialization; (2) working in the pharmaceutical/veterinary sciences industry; (3) program management, and strategic process improvement; (4) guiding, coaching, and developing teams in a matrix environment, coupled with product launch and program management; (5) Cross-functional, launch-related expertise in Manufacturing & Quality, Research & Development, Regulatory Affairs, and commercial matters; and (6) and identifying interdependencies and mitigate related risks for product launches.
- PMP certification required.
- 10% domestic and international travel required for team meetings and to facilitate product launches.
- Must live within a commutable distance to the assigned Elanco Office location to meet 30 days per quarter work from office requirement.
Requirements
- Bachelor’s degree in Veterinary Science, a related field, or a foreign equivalent
- 5 years of progressively responsible experience in product-launch related roles
- 5 years of experience applying knowledge of veterinary products, clinical knowledge of animal health, disease treatment, and veterinary practice environments for product commercialization
- 5 years of experience working in the pharmaceutical/veterinary sciences industry
- 5 years of experience in program management and strategic process improvement
- 5 years of experience guiding, coaching, and developing teams in a matrix environment, coupled with product launch and program management
- 5 years of cross-functional, launch-related expertise in Manufacturing & Quality, Research & Development, Regulatory Affairs, and commercial matters
- 5 years of experience identifying interdependencies and mitigating related risks for product launches
- PMP certification required
- 10% domestic and international travel required
- Must live within a commutable distance to the assigned Elanco Office location to meet 30 days per quarter work from office requirement
Company overview
Elanco Animal Health Incorporated is a global leader in the animal health pharmaceutical industry, dedicated to improving the health and well-being of both pets and farm animals worldwide. Founded in 1954 as a division of Eli Lilly and Company, Elanco became an independent public company in 2018 and has since grown to become the world's second-largest independent animal health company. With approximately 9,000 employees globally, the company operates with a clear purpose: 'making life better for animals, makes life better.' Elanco develops innovative medicines, vaccines, and health solutions that empower veterinarians, farmers, and pet owners to advance animal care. The company maintains a balanced portfolio between pet health and farm animal products, offering over 200 brands that address critical health challenges ranging from companion animal diseases to livestock productivity. Headquartered in Indianapolis, Indiana, Elanco is publicly traded on the New York Stock Exchange (NYSE: ELAN) and continues to drive innovation in animal health through strategic acquisitions and dedicated research and development efforts.